Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities
- PMID: 7493610
- DOI: 10.1016/0014-2999(95)00069-w
Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities
Abstract
The potencies for in vivo inhibition of substantia nigra pars compacta dopamine single cell firing were determined for apomorphine, BHT 920, N-0923, (+/-)-7-hydroxy-dipropylaminotetralin (7-OH-DPAT), (+)-3-(3-hydroxyphenyl)-N-propylpiperidine (3-PPP), pramipexole, quinelorane, quinpirole, RU 24926, U-86170, and U-91356. Significant correlation was obtained between the potencies of these 11 highly efficacious dopamine receptor agonists and the in vitro binding affinities at dopamine D3 receptors, but not at dopamine D2L receptors. These results support a functional role for the dopamine D3 receptor subtype in the autoreceptor-mediated regulation of dopamine cell activity, while a role for dopamine D2 receptors awaits further analysis. In addition, the results demonstrate the limitations of using currently available dopamine receptor agonists to delineate relative in vivo roles for the dopamine D2 and D3 receptor subtypes.
Similar articles
-
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.Eur J Pharmacol. 1994 Oct 3;263(3):235-43. doi: 10.1016/0014-2999(94)90718-8. Eur J Pharmacol. 1994. PMID: 7843260
-
Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.Eur J Pharmacol. 1995 Jun 23;290(1):29-36. doi: 10.1016/0922-4106(95)90013-6. Eur J Pharmacol. 1995. PMID: 7664822
-
Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.Brain Res. 1997 Jul 11;762(1-2):19-28. doi: 10.1016/s0006-8993(97)00369-7. Brain Res. 1997. PMID: 9262154
-
Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.Eur J Pharmacol. 1986 Apr 16;123(2):237-51. doi: 10.1016/0014-2999(86)90665-5. Eur J Pharmacol. 1986. PMID: 2940101 Review.
-
Functional models for the dopamine D3 receptor.Biochem Soc Trans. 1996 Feb;24(1):193-8. doi: 10.1042/bst0240193. Biochem Soc Trans. 1996. PMID: 8674660 Review. No abstract available.
Cited by
-
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):436-41. doi: 10.1136/jnnp.66.4.436. J Neurol Neurosurg Psychiatry. 1999. PMID: 10201413 Free PMC article. Clinical Trial.
-
In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.Br J Pharmacol. 1996 Apr;117(8):1625-32. doi: 10.1111/j.1476-5381.1996.tb15332.x. Br J Pharmacol. 1996. PMID: 8732269 Free PMC article.
-
Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo.J Neurosci. 1997 Apr 1;17(7):2519-30. doi: 10.1523/JNEUROSCI.17-07-02519.1997. J Neurosci. 1997. PMID: 9065512 Free PMC article.
-
KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis.CNS Neurosci Ther. 2008 Fall;14(3):215-26. doi: 10.1111/j.1755-5949.2008.00048.x. CNS Neurosci Ther. 2008. PMID: 18801114 Free PMC article. Review.
-
Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.Br J Pharmacol. 1996 Dec;119(7):1491-7. doi: 10.1111/j.1476-5381.1996.tb16063.x. Br J Pharmacol. 1996. PMID: 8968560 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous